Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Rankning i aktier #4732
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktiekurs
$48.46
Marknadsvärde
$3.35B
Förändring (1 dag)
-1.09%
Förändring (1 år)
186.60%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)

Kategori

Utdelningsavkastning för Pulse Biosciences, Inc. (PLSE)
Utdelningsavkastningen (TTM) för Pulse Biosciences, Inc. (aktiesymbol: PLSE) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Pulse Biosciences, Inc. (PLSE) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter